Board- Haiying Grunenwald
Sector: Life Science Reagents
Location: Madison, Wisconsin
About Illumina: At Illumina, their goal is to apply innovative technologies to analyze genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission-critical for them to deliver innovative, flexible, and scalable solutions to meet our customers' needs. As a global company that places a high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, they strive to meet this challenge. Illumina’s innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.
Bio Highlights: Haiying is a Director of Product Development at Illumina Inc. She has a strong track record of driving successful product development and has led some of the company’s most impactful product launches in research, clinical, and applied markets. Haiying received her Ph.D. in Molecular, Cellular, Developmental Biology and Genetics from the University of Minnesota – Twin Cities, where she conducted in-depth studies on the effects of connexins and gap junctions on cellular communication and cancer. She has garnered a reputation for leading teams as catalysts of change that advanced Illumina’s NGS portfolio and drove research discoveries, and improved patient care globally. Born and raised in China and an avid world traveler, Haiying strives to bridge the Asian and western cultures and ideologies. In doing so, she thrives on facilitating success through collaboration, tolerance, and inclusion.